![Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans - eBioMedicine Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans - eBioMedicine](https://www.thelancet.com/cms/attachment/da6c7da1-69a9-4197-86e6-db2728d9bdd1/gr1_lrg.jpg)
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans - eBioMedicine
![Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease](https://assets.cureus.com/uploads/figure/file/371294/lightbox_4c60b210d24311ec9ff5b543b3308bff-CVD-in-NAFLD-Final-May-12-Pixlated.png)
Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease
![JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction? JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?](https://www.mdpi.com/jcm/jcm-10-00924/article_deploy/html/images/jcm-10-00924-g001.png)
JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
![Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment](https://www.frontiersin.org/files/Articles/615978/fmed-08-615978-HTML/image_m/fmed-08-615978-g001.jpg)
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
![CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression | Science Advances CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression | Science Advances](https://www.science.org/cms/10.1126/sciadv.abc5022/asset/195af09a-9047-4759-9866-1f8dd61c6b46/assets/graphic/abc5022-f1.jpeg)
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression | Science Advances
![Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients | Molecular Systems Biology Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients | Molecular Systems Biology](https://www.embopress.org/cms/asset/838325bc-fa7d-4c1e-89af-6caf89978d42/msb202110459-abs-0001-m.jpg)
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients | Molecular Systems Biology
![PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/08a2fcbbf0d1a9facdeb9e8821b60b9039ad130a/2-Figure1-1.png)
PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar
![Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement - The Lancet Gastroenterology & Hepatology Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/c565b101-01a7-46d7-859f-e4d55d040167/gr1.jpg)
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement - The Lancet Gastroenterology & Hepatology
![Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-020-00579-3/MediaObjects/41423_2020_579_Fig1_HTML.png)
Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology
![Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism](https://www.cell.com/cms/attachment/7f3bf374-7a0d-4e57-93b3-3c4749581c88/gr1_lrg.jpg)
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism
![Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin](https://www.explorationpub.com/uploads/Article/A100119/100119-g001.jpg)
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
![Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42255-021-00501-9/MediaObjects/42255_2021_501_Fig1_HTML.png)
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism
![Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aadbc2ab-65a0-4957-8a0a-73a0e0959726/edm2177-toc-0001-m.jpg?trick=1675662199880)
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis - Tincopa - 2020 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
![A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004220311287-fx1.jpg)
A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect
![Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism](https://www.cell.com/cms/attachment/af971a03-3b29-4d9f-bb62-fea7c9f4018c/gr3_lrg.jpg)
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease: Trends in Endocrinology & Metabolism
Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population | PLOS ONE
![JCI - Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice JCI - Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice](https://dm5migu4zj3pb.cloudfront.net/manuscripts/127000/127502/medium/JCI127502.ga.jpg)
JCI - Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice
![A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study | Scientific Reports A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-05168-0/MediaObjects/41598_2022_5168_Fig1_HTML.png)
A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study | Scientific Reports
![Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827821021504-ga1.jpg)
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect
![Role of hepatic fatty acid metabolism in the development of hepatic... | Download Scientific Diagram Role of hepatic fatty acid metabolism in the development of hepatic... | Download Scientific Diagram](https://www.researchgate.net/publication/282039812/figure/fig1/AS:614202704150531@1523448744392/Role-of-hepatic-fatty-acid-metabolism-in-the-development-of-hepatic-steatosis-Hepatic.png)